VASCULAR ENDOTHELIAL MYOSTATIN MUTANT THAT MUTATES AT ATP BINDING SITES

摘要

The present invention discloses a new anti-tumor medicament comprising a mutant of endostatin. The mutant comprises a mutation in the ATP-binding site of endostatin and has a decreased ATPase activity and an increased anti-angiogenesis activity.